Literature DB >> 16501119

Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.

Aymeric de Parseval1, Chris K Grant, K Jagannadha Sastry, John H Elder.   

Abstract

Recombinant soluble CD134 (sCD134) facilitated feline immunodeficiency virus (FIV) entry into CXCR4-positive, cell surface CD134-negative target cells. sCD134-activated entry was dose dependent and CXCR4 dependent. We used the sCD134 activation system to explore the neutralization by four anti-V3 monoclonal antibodies (MAbs). V3 MAbs weakly neutralized FIV infection using target cells expressing both CD134 and CXCR4 but potently inhibited sCD134-activated entry into target cells expressing CXCR4 alone. These findings provide direct evidence for a sequential interaction of FIV Env with CD134 and CXCR4 and reveal the presence of a cryptic epitope in V3 that is masked in the mature envelope oligomers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501119      PMCID: PMC1395450          DOI: 10.1128/JVI.80.6.3088-3091.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Chemokine receptors and HIV entry.

Authors:  R W Doms
Journal:  AIDS       Date:  2001-02       Impact factor: 4.177

2.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.

Authors:  Aymeric de Parseval; Udayan Chatterji; Garrett Morris; Peiqing Sun; Arthur J Olson; John H Elder
Journal:  Nat Struct Mol Biol       Date:  2004-12-12       Impact factor: 15.369

4.  Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.

Authors:  Barna Dey; Christie S Del Castillo; Edward A Berger
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor.

Authors:  Aymeric de Parseval; Udayan Chatterji; Peiqing Sun; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

6.  Use of CD134 as a primary receptor by the feline immunodeficiency virus.

Authors:  Masayuki Shimojima; Takayuki Miyazawa; Yasuhiro Ikeda; Elizabeth L McMonagle; Hayley Haining; Hiroomi Akashi; Yasuhiro Takeuchi; Margaret J Hosie; Brian J Willett
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

7.  Localisation of three epitopes of the env protein of feline immunodeficiency virus.

Authors:  A Avrameas; J G Guillet; L Chouchane; A Moraillon; P Sonigo; A D Strosberg
Journal:  Mol Immunol       Date:  1992-05       Impact factor: 4.407

8.  Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.

Authors:  Sohela de Rozières; Candace K Mathiason; Matthew R Rolston; Udayan Chatterji; Edward A Hoover; John H Elder
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.

Authors:  Aymeric de Parseval; Stacie Ngo; Peiqing Sun; John H Elder
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.

Authors:  G Pancino; C Chappey; W Saurin; P Sonigo
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more
  28 in total

Review 1.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 2.  Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

Authors:  John H Elder; Ying-Chuan Lin; Elizabeth Fink; Chris K Grant
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

3.  Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection.

Authors:  Britta A Wood; Scott Carver; Ryan M Troyer; John H Elder; Sue VandeWoude
Journal:  J Immunol Methods       Date:  2013-08-14       Impact factor: 2.303

4.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

5.  Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.

Authors:  Chris K Grant; Elizabeth A Fink; Magnus Sundstrom; Bruce E Torbett; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

Review 6.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

7.  Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; Pascal Schneider; Margaret J Hosie
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

8.  Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Yang Hong; Cathy Wang; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

9.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

10.  Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.

Authors:  Simone Giannecchini; Anna Maria D'Ursi; Cinzia Esposito; Mario Scrima; Elisa Zabogli; Giulia Freer; Paolo Rovero; Mauro Bendinelli
Journal:  Clin Vaccine Immunol       Date:  2007-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.